Skip to content

Lupumed: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Lupumed

BE 0761.553.829
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€843,196
2024 · €84,847+€758,349
Equity
€5,196
2024 · €482,496-€477,300
Cash
€645,610
2024 · €307,287+€338,324
Balance sheet total
€2.1m
2024 · €1.1m+€937,561

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€745,130

    up €745,130 (+121.9%), from €611,099 to €1.4m

    of which Trade receivables: +€626,002

  • Cash +€338,324

    up €338,324 (+110.1%), from €307,287 to €645,610

    mainly Other debts (+€1.1m) and Net result for the year (+€843,196)

  • Financial fixed assets -€200,000

    down €200,000 (-100.0%), from €200,000 to €0

  • Tangible fixed assets +€30,183

    up €30,183 (+1015.1%), from €2,974 to €33,157

    of which Plant, machinery and equipment: +€19,700

  • Stocks and contracts +€22,125

    up €22,125 (+108.9%), from €20,309 to €42,434

Equity and liabilities
  • Other debts +€1.1m

    up €1.1m (+961.5%), from €117,647 to €1.2m

  • Reserves -€477,300

    down €477,300 (-100.0%), from €477,496 to €196

  • Trade debts +€282,655

    up €282,655 (+52.1%), from €542,275 to €824,930

Income statement
  • Gross operating margin +€703,292

    up €703,292 (+631.2%), from €111,423 to €814,715

  • Financial income +€35,205

    up €35,205 (+17005.8%), from €207 to €35,412

    of which Non-recurring financial income: +€35,000

  • Taxes -€22,968

    down €22,968 (-95.9%), from €23,950 to €982

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €84,847
Gross operating margin +€703,292
Depreciation -€3,067
Other operating charges -€262
Financial income +€35,205
Financial charges +€213
Taxes +€22,968
Result 2025 €843,196

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€1.5m
Investment +€165,463
Financing -€1.3m
Cash 2024 €307,287
Net result for the year +€843,196
Depreciation +€4,354
Stocks and contracts -€22,125
Receivables within one year -€745,130
Smaller working-capital items -€817
Trade debts +€282,655
Other debts +€1.1m
Investment in fixed assets (net) +€165,463
Contributions, distributions and other -€1.3m
Cash 2025 €645,610
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,142,418 €2,079,979 +€937,561 +82.1%
Fixed assets 21/28 €202,974 €33,157 -€169,817 -83.7%
Tangible fixed assets 22/27 €2,974 €33,157 +€30,183 +1015.1%
Plant, machinery and equipment 23 €2,471 €22,171 +€19,700 +797.3%
Furniture and vehicles 24 €503 €240 -€263 -52.3%
Other tangible fixed assets 26 - €10,746 +€10,746
Financial fixed assets 28 €200,000 €0 -€200,000 -100.0%
Current assets 29/58 €939,444 €2,046,822 +€1.1m +117.9%
Stocks and contracts in progress 3 €20,309 €42,434 +€22,125 +108.9%
Stocks 30/36 €20,309 €42,434 +€22,125 +108.9%
Amounts receivable within one year 40/41 €611,099 €1,356,229 +€745,130 +121.9%
Trade receivables 40 €437,777 €1,063,779 +€626,002 +143.0%
Other amounts receivable 41 €173,322 €292,450 +€119,128 +68.7%
Cash at bank and in hand 54/58 €307,287 €645,610 +€338,324 +110.1%
Deferred charges and accrued income 490/1 €750 €2,549 +€1,799 +240.0%
Total equity and liabilities 10/49 €1,142,418 €2,079,979 +€937,561 +82.1%
Equity 10/15 €482,496 €5,196 -€477,300 -98.9%
Contributions 10/11 €5,000 €5,000 = 0.0%
Reserves 13 €477,496 €196 -€477,300 -100.0%
Distributable reserves 133 €477,496 €196 -€477,300 -100.0%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €659,922 €2,074,783 +€1.4m +214.4%
Amounts payable within one year 42/48 €659,922 €2,074,783 +€1.4m +214.4%
Trade debts 44 €542,275 €824,930 +€282,655 +52.1%
Suppliers 440/4 €542,275 €824,930 +€282,655 +52.1%
Taxes, remuneration and social security 45 €0 €982 +€982
Taxes 450/3 €0 €982 +€982
Other amounts payable 47/48 €117,647 €1,248,871 +€1.1m +961.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,286 €4,354 +€3,067 +238.4%
Other operating charges 640/8 €1,172 €1,434 +€262 +22.4%
Gross operating margin 9900 €111,423 €814,715 +€703,292 +631.2%
Operating profit (loss) 9901 €108,965 €808,928 +€699,963 +642.4%
Financial income 75/76B €207 €35,412 +€35,205 +17005.8%
Recurring financial income 75 €207 €412 +€205 +99.2%
Non-recurring financial income 76B - €35,000 +€35,000
Financial charges 65/66B €375 €162 -€213 -56.8%
Recurring financial charges 65 €375 €162 -€213 -56.8%
Profit (loss) for the period before taxes 9903 €108,796 €844,178 +€735,381 +675.9%
Income taxes 67/77 €23,950 €982 -€22,968 -95.9%
Profit (loss) for the period 9904 €84,847 €843,196 +€758,349 +893.8%
Profit (loss) for the period to be appropriated 9905 €84,847 €843,196 +€758,349 +893.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.